Welcome to the Extreme Investor Network blog, where we provide you with exceptional insights and unique information to help you make informed investing decisions. Today, we are diving into the latest analyst calls and Wall Street chatter to give you an edge in the market.
First up, Barclays has upgraded CVS to overweight from equal weight, with a call for 24% upside. Analyst Andrew Mok sees a compelling margin recovery opportunity for CVS, citing early signs of a Medicare margin recovery. This could unlock significant value at Aetna, the pharmaceutical company’s parent company.
On the flip side, JPMorgan has downgraded Honeywell International to neutral from overweight. Analyst Stephen Tusa raised the price target but expressed concerns about the company’s bottom line performance amidst a renewed focus on organic growth. Despite a positive outlook for 2025, there may be some trade-offs in terms of margins.
In the electric vehicle charging space, UBS upgraded EVgo to buy from neutral, with a price target of $8.50. Analyst William Gripping highlighted major tailwinds for EVgo, including a recent $1.05 billion loan conditional commitment from the Department of Energy. With the decreased odds of a Republican sweep in the November election, EVgo’s outlook is also looking promising.
Moving on to the insurance sector, JPMorgan upgraded AIG to overweight from neutral, despite trimming the price target. Analyst Jimmy Bhullar sees expected outsized EPS growth for AIG over the next few years, driven by lower exposure to risks facing commercial insurers and high capital flexibility.
At Extreme Investor Network, we believe in empowering investors with in-depth analysis and expert insights. Stay tuned for more exclusive content to help you navigate the ever-changing world of investing.